Abu-Arafeh I, Razak S, Sivaraman B, Graham C (2010) Prevalence of headache and migraine in children and adolescents: a systematic review of population‐based studies. Develop Med Child Neuro Dicembre 52(12):1088–1097
Serrano D, Lipton RB, Scher AI, Reed ML, Stewart WF, Adams AM et al (2017) Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. J Headache Pain Dicembre 18(1):101
Bigal ME, Lipton RB (2008) Clinical course in migraine: conceptualizing migraine transformation. Neurol 9 Settembre 71(11):848–855
Bigal ME, Lipton RB (2008) Concepts and mechanisms of Migraine Chronification. Headache Gennaio 48(1):7–15
Bigal ME, Lipton RB (2006) When migraine progresses: transformed or chronic migraine. Expert Rev Neurother Marzo 6(3):297–306
Lipton RB, Buse DC, Nahas SJ, Tietjen GE, Martin VT, Löf E et al (2023) Risk factors for migraine disease progression: a narrative review for a patient-centered approach. J Neurol Dicembre 270(12):5692–5710
Zwart JA, Dyb G, Holmen T, Stovner L, Sand T (2004) The prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trøndelag Health Study (Head-Hunt-Youth), a large Population-based epidemiological study. Cephalalgia Maggio 24(5):373–379
Kernick D, Campbell J (2009) Measuring the impact of Headache in children: a critical review of the literature. Cephalalgia Gennaio 29(1):3–16
Arruda MA, Guidetti V, Galli F, Albuquerque RCAP, Bigal ME (2010) Frequent headaches in the preadolescent pediatric population: a population-based study. Neurol 16 Marzo 74(11):903–908
Headache Classification Committee of the International Headache Society (IHS) (2018);38(1):1–211
Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P (2011) Prevalence and burden of chronic migraine in adolescents: results of the Chronic Daily Headache in adolescents Study (C-dAS). Headache Maggio 51(5):693–706
De Felice M, Ossipov MH, Porreca F (2011) Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache. Curr Opin Neurol Giugno 24(3):193–196
De Felice M, Ossipov MH, Wang R, Lai J, Chichorro J, Meng I et al (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Annals Neurol Marzo 67(3):325–337
Felice MD, Porreca F (2009) Opiate-Induced Persistent Pronociceptive Trigeminal neural adaptations: potential relevance to Opiate-Induced Medication Overuse Headache. Cephalalgia Dicembre 29(12):1277–1284
Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurol 25 Novembre 71(22):1821–1828
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurol 9 Marzo 62(5):788–790
Louter MA, Bosker JE, Van Oosterhout WPJ, Van Zwet EW, Zitman FG, Ferrari MD et al (2013) Cutaneous allodynia as a predictor of migraine chronification. Brain Novembre 136(11):3489–3496
Wang SJ, Fuh JL, Lu SR, Juang KD (2007) Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurol 20 Febbraio 68(8):591–596
Sacco S, Lampl C, Amin FM, Braschinsky M, Deligianni C, Uludüz D et al (2022) European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. J Headache Pain Dicembre 23(1):133
Ferrari M, Goadsby P, Roon K, Lipton R (2002) Triptans (serotonin, 5-HT 1B/1D agonists) in migraine: detailed results and methods of a Meta-analysis of 53 trials. Cephalalgia Ottobre 22(8):633–658
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet Novembre 358(9294):1668–1675
Cady RK, Wendt JK, Kirchner JR (1991) Treatment of acute migraine with subcutaneous suma- triptan. JAMA.;(265):2831–2835
Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML (2016) Predicting inadequate response to Acute Migraine Medication: results from the A merican migraine prevalence and Prevention (AMPP) Study. Headache Novembre 56(10):1635–1648
Saracco MG, Allais G, Tullo V, Zava D, Pezzola D, Reggiardo G et al (2014) Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies. Neurol Sci Maggio 35(S1):115–119
Papetti L, Salfa I, Battan B, Moavero R, Termine C, Bartoli B et al (2019) Features of primary chronic headache in children and adolescents and Validity of Ichd 3 Criteria. Front Neurol 15 Febbraio 10:92
Moavero R, Stornelli M, Papetti L, Ursitti F, Ferilli MAN, Balestri M et al (2020) Medication overuse withdrawal in children and adolescents does not always improve headache: a cross-sectional study. Front Neurol 19 Agosto 11:823
Stevens J, Hayes J, Pakalnis A (2014) A randomized trial of telephone-based motivational interviewing for adolescent chronic headache with medication overuse. Cephalalgia Maggio 34(6):446–454
Langdon R, DiSabella MT (2017) Pediatric Headache: an overview. Curr Probl Pediatr Adolesc Health Care Marzo 47(3):44–65
Heyer GL, Idris SA (2014) Does Analgesic Overuse Contribute to Chronic Post-traumatic Headaches in Adolescent Concussion Patients? Pediatric Neurology. maggio.;50(5):464–8
Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does Chronic Daily Headache Arise De Novo in Association With Regular Use of Analgesics? Headache. marzo.;43(3):179–90
Wilkinson SM, Becker WJ, Heine JA (2001) Opiate Use to Control Bowel Motility May Induce Chronic Daily Headache in Patients With Migraine. Headache. 30 marzo.;41(3):303–9
Consortium COMOESTAS, Find NL, Terlizzi R, Munksgaard SB, Bendtsen L, Tassorelli C et al (2016) Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain Dicembre 17(1):20
Papetti L, Ursitti F, Moavero R, Ferilli MAN, Sforza G, Tarantino S et al (2019) Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade? Front Neurol. 16 luglio.;10:771
Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: epidemiology, diagnosis and treatment. Therapeutic Adv Drug Saf Aprile 5(2):87–99
Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M et al (2009) Family History for Chronic Headache and Drug Overuse as a risk factor for Headache Chronification. Headache Marzo 49(3):412–418
Cupini LM, De Murtas M, Costa C, Mancini M, Eusebi P, Sarchielli P et al (2009) Obsessive-compulsive disorder and migraine with medication‐overuse headache. Headache Luglio 49(7):1005–1013
Odegard MN, Ceasar RC, Hijaz D, Obinelo A, Rosales A, Bhanvadia S et al Adolescent and parent perceptions of postoperative opioid use: a qualitative, thematic analysis. Journal of Pediatric Surgery. dicembre 2023;S002234682300756X.
Sarchielli P, Corbelli I, Messina P, Cupini LM, Bernardi G, Bono G et al (2016) Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. Euro J Neurol Gennaio 23(1):85–91
Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J et al (2005) Topiramate for Migraine Prevention in children: a Randomized, Double-Blind, Placebo‐Controlled Trial. Headache Novembre 45(10):1304–1312
FDA approves Topamax for migraine prevention in adolescents (2014) J Pain Palliat Care Pharmacother Giugno 28(2):191
Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW et al (2017) Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med. 12 gennaio.;376(2):115–24
Ludvigsson J, PROPRANOLOL, USED IN PROPHYLAXIS OF MIGRAINE IN CHILDREN (2009) Acta Neurol Scand 29 Gennaio 50(1):109–115
Sorge F, Simone RD, Marano E, Nolano M, Orefice G, Carrieri P (1988) Flunarizine in Prophylaxis of Childhood Migraine: a Double-Blind, Placebo-Controlled, crossover study. Cephalalgia Marzo 8(1):1–6
Ashrafi MR, Salehi S, Malamiri RA, Heidari M, Hosseini SA, Samiei M et al (2014) Efficacy and safety of Cinnarizine in the Prophylaxis of Migraine in children: a double-blind placebo-controlled Randomized Trial. Pediatr Neurol Ottobre 51(4):503–508
Battistella PA, Ruffilli R, Moro R, Fabiani M, Bertoli S, Antolini A et al (1990) A placebo-controlled crossover trial of Nimodipine in Pediatric Migraine. Headache Aprile 30(5):264–268
Gesztelyi G (2004) [Primary headache and depression]. Orv Hetil 28 Novembre 145(48):2419–2424
Tarantino S, Papetti L, Di Stefano A, Messina V, Ursitti F, Ferilli MAN et al (2020) Anxiety, Depression, and Body Weight in Children and adolescents with Migraine. Front Psychol 28 Ottobre 11:530911
Guidetti V, Galli F, Fabrizi P, Giannantoni A, Napoli L, Bruni O et al (1998) Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia Settembre 18(7):455–462
Lantéri-Minet M, Radat F, Chautard MH, Lucas C (2005) Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain Dicembre 118(3):319–326
Lewandowski AS, Palermo TM, Peterson CC (2006) Age-Dependent relationships among Pain, depressive symptoms, and functional disability in Youth with recurrent headaches. Headache Aprile 46(4):656–662
留言 (0)